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Edited by Sandro SonninoAbstract We investigated the expression of formyl peptide
receptor (FPR) and its functional role in human bone marrow-
derived mesenchymal stem cells (MSCs). We analyzed the
expression of FPR by using ligand-binding assay with radio-
labeled N-formyl-met-leu-phe (fMLF), and found that MSCs
express FPR. FMLF stimulated intracellular calcium increase,
mitogen-activated protein kinases activation, and Akt activation,
which were mediated by Gi proteins. MSCs were chemotactically
migrated to fMLF. FMLF-induced MSC chemotaxis was also
completely inhibited by pertussis toxin, LY294002, and
PD98059, indicating the role of Gi proteins, phosphoinositide
3-kinase, and extracellular signal regulated protein kinase. N-
terminal fragment of annexin-1, Anx-1(2–26), an endogenous
agonist for FPR, also induced chemotactic migration of MSCs.
Thus MSCs express functional FPR, suggesting a new
(patho)physiological role of FPR and its ligands in regulating
MSC traﬃcking during induction of injured tissue repair.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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G-protein1. Introduction
Since mesenchymal stem cells (MSCs) are precursors that
can be diﬀerentiated into several specialized cell types and tis-
sues, they have been regarded as an important therapeutic tool
for clinical application in the ﬁeld of damaged tissue remodel-
ing and so on [1]. For the proper action of MSCs to diﬀeren-Abbreviations: MSCs, mesenchymal stem cells; FPR, formyl peptide
receptor; fMLF, N-formyl-met-leu-phe; CsH, cyclosporine H; PTX,
pertussis toxin; LY294002, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopy-
ran-4-one; Fura-2/AM, fura-2 pentaacetoxymethylester; BAPTA/AM,
1,2-bis(o-aminophenoxy)ethane-N,N,N0,N0-tetraacetic acid tetra(acet-
oxymethyl) ester; ERK, extracellular signal regulated protein kinase;
PD98059, 2 0-amino-30-methoxyﬂavone; SB203580, 4-(4-ﬂuorophenyl)-
2-(4-methylsulfonylphenyl)-5-(4-pyridyl)-1H-imidazole; [Ca2+]i, intra-
cellular calcium concentration; MAPK, mitogen-activated protein
kinase; PI3K, phosphoinositide 3-kinase
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doi:10.1016/j.febslet.2007.03.078tiate into a certain type of cells in a speciﬁc location, MSCs
should migrate to a site of injury. Several factors that regulate
MSC migration have been reported. They include some che-
mokines including stromal-derived factor-1 [2,3].
Formyl peptide receptor (FPR), a chemoattractant receptor,
is mainly expressed in phagocytic cells and plays an important
role in host defense against pathogen infection [4]. Activation
of FPR induces diverse cellular responses including chemotac-
tic migration and superoxide generation [4]. Recently FPR also
has been reported to be expressed in non-phagocytic cells, such
as ﬁbroblasts [5]. Very recently Viswanathan et al. reported
that human bone marrow-derived mesenchymal stem cells
express functional FPRs [6].
In this study, we investigated the eﬀect of FPR agonists on
the chemotactic migration of MSCs and the signaling pathway
involved in the process.2. Materials and methods
2.1. Materials
N-Formyl-met-leu-phe (fMLF) was purchased from Sigma (St.
Louis, MO). [3H]-labeled fMLF was obtained from Perkin–Elmer Life
Sciences, Inc. (Boston,MA). Cyclosporin H (CsH) was kindly provided
by Novartis Pharma (Basel, Switzerland). N-terminal fragment of an-
nexin-1, Anx-1(2–26), was purchased from Phoenix Pharmaceuticals,
Inc. (Burlingame, CA). Pertussis toxin (PTX) and 2-(4-morpholinyl)-
8-phenyl-4H-1-benzopyran-4-one (LY294002) were from Calbiochem
(San Diego, CA). Fura-2 pentaacetoxymethylester (fura-2/AM) and
1,2-bis(o-aminophenoxy)ethane-N,N,N 0,N 0-tetraacetic acid tetra(acet-
oxymethyl) ester (BAPTA/AM) were purchased from Molecular
Probes (Eugene, OR). Enhanced chemiluminescence reagents from
Amersham Biosciences (Piscataway, NJ), phospho-extracellular signal
regulated protein kinase (ERK)1/2, phospho-p38 and ERK2 antibodies
were purchased from New England Biolabs (Beverly, MA). Phospho-
Akt antibody, Akt antibody, ﬁbrinogen, and ﬁbronectin were pur-
chased from Sigma (St. Louis, MO). 2 0-Amino-3 0-methoxyﬂavone
(PD98059) and 4-(4-ﬂuorophenyl)-2-(4-methylsulfonylphenyl)-5-(4-
pyridyl)-1H-imidazole (SB203580) were obtained from Biomol (Plym-
outh Meeting, PA) and were dissolved in dimethyl sulfoxide before
being added to the cell culture. The ﬁnal concentrations of dimethyl
sulfoxide in culture were 0.1% or less.
2.2. Isolation and culture of MSCs
Human bone marrow stem cells were isolated as described previ-
ously [7]. Bone marrow stromal cells were isolated and were plated
in T75 ﬂasks for continuous passage in aMEM medium supplemented
with 20% fetal bovine serum and 1% antibiotic–antimycotic solution.
Medium was changed twice weekly, cells detached by trypsin–EDTA
and under passage into fresh culture ﬂasks at a ratio of 1:4 uponblished by Elsevier B.V. All rights reserved.
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incubator with 5% CO2. Diﬀerent phenotypic markers of human mes-
enchymal stem cells including CD29, CD44 and CD66 were employed
to conﬁrm the stem cell-like feature of the isolated stromal cells. All the
experiments were done using within passage 6 MSCs. The experimental
procedures were approved by the Institutional Review Board of Seoul
National University Dental Hospital.
2.3. Ligand-binding assay
MSCs were seeded at 5 · 104 cells per well into a 24-well plate and
cultured overnight. Several concentrations of [3H]-labeled fMLF were
added to the cells in the absence or presence of unlabelled 10 lM
fMLF or 10 lM CsH for 3 h at 4 C with continuous shaking. Speciﬁc
binding of [3H]-labeled fMLF was counted using a b-ray counter [8].
2.4. Measurement of intracellular calcium concentration
Intracellular calcium concentration [Ca2+]i was determined using
fura-2/AM [9]. Brieﬂy, MSCs were incubated with 3 lM fura-2/AM
at 37 C for 50 min in fresh serum free aMEM medium with continu-
ous stirring. 2 · 106 Cells were aliquoted for each assay into Locke’s
solution [9]. Fluorescence was measured at 500 nm at excitation wave-
lengths of 340 nm and 380 nm.
2.5. Western blot analysis
MSCs (2 · 106) were stimulated with the indicated concentrations of
fMLF. Cell extracts were separated in 10% SDS–polyacrylamide gel
and, the proteins were blotted onto a nitrocellulose membrane. Subse-
quently, membranes were incubated with speciﬁc antibodies. Antigen–
antibody complexes were visualized after incubating the membraneC

















































Fig. 1. Functional expression of FPR in MSCs. Several concentrations of [3H
or presence of 10 lM of unlabeled fMLF (A). 50 pM [3H]-labeled fMLF w
10 lM of CsH (B). The quantity of bound [3H]-labeled fMLF was determin
three independent experiments (A, B). MSCs were then loaded with fura-2/A
several concentrations of fMLF in the absence or presence of CsH (10 lM
experiments (C). Three diﬀerently prepared MSCs were preincubated in the a
with 1 lM of fMLF (D). Relative intracellular Ca2+ concentrations are expres
independent experiments (D). * indicates results signiﬁcantly diﬀerent at the P
control (-fMLF). # indicates results signiﬁcantly diﬀerent at the P < 0.05 pr
(DMSO treated).with 1:5000 diluted goat anti-rabbit IgG antibody coupled to horserad-
ish peroxidase and detected by enhanced chemiluminescence.
2.6. Chemotaxis assay
Chemotaxis assays were performed using multiwell chambers (Neu-
roprobe Inc. Gaithersburg, MD) [10]. Polycarbonate membrane of 96-
well chemotaxis chamber was precoated with ﬁbronectin (20 lg/ml).
MSCs were suspended in aMEM at 1 · 106 cells/ml, and 25 ll of this
suspension was placed into the upper well of a chamber separated by
an 8 lm precoated polyhydrocarbon ﬁlter from the peptide containing
lower well. After incubation for 12 h at 37 C, migrated cells were then
counted in three randomly chosen high power ﬁelds (400·) [10].
2.7. Statistics
The results are expressed as means ± S.E. of the number of determi-
nations indicated. Statistical signiﬁcance of diﬀerences was determined
by ANOVA. Signiﬁcance was accepted when P < 0.05.3. Results
3.1. Expression of FPR in MSCs
To investigate whether MSCs express FPR, we performed a
ligand-binding assay using [3H] fMLF in MSCs. The addition
of various concentrations of [3H] fMLF demonstrated the
concentration-dependent binding of [3H] fMLF to MSCs
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Fig. 3. Activation of Akt by fMLF in MSCs. MSCs were stimulated
with 1 lM of fMLF for various times (A). The cells were stimulated
with various concentrations of fMLF for 5 min (B). MSCs were
preincubated in the absence or presence of 100 ng/ml of PTX for 24 h.
Cells were stimulated with 1 lM of fMLF for 5 min (C). Western blot
analysis was performed using anti-phospho-Akt antibody. The results
shown are representative of at least three independent experiments
(A–C).
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adding 0.5 pM of [3H] fMLF, which achieved saturation at ca.
20 pM of [3H] fMLF for 5 · 104 cells (Fig. 1A). The speciﬁc
binding of 50 pM of [3H] fMLF was almost completely inhib-
ited by 10 lM of CsH (Fig. 1B). These results indicate that
MSCs express FPR.
3.2. FMLF stimulates intracellular calcium increase via
PTX-sensitive G-protein in MSCs
Previously it has been demonstrated that the activation of
FPR by fMLF causes [Ca2+]i increases [11]. To conﬁrm that
FPR on MSCs is functional, we examined the eﬀect of fMLF
upon [Ca2+]i in MSCs. Stimulation of MSCs with several con-
centrations of fMLF caused [Ca2+]i increase in a concentra-
tion-dependent manner, showing maximal activity at 1 lM
fMLF (Fig. 1C). We also examined the eﬀect of PTX, a speciﬁc
inhibitor of Gi/o type G-proteins, on fMLF-induced [Ca
2+]i in-
crease. When MSCs were preincubated with 100 ng/ml of PTX
prior to being stimulated with 1 lM fMLF, fMLF-induced
[Ca2+]i increase was completely inhibited (Fig. 1D). FMLF-in-
duced [Ca2+]i increase was commonly observed from three dif-
ferently prepared MSCs (Fig. 1D). These results indicate that
fMLF stimulates [Ca2+]i increase via PTX-sensitive pathway.
3.3. FMLF stimulates mitogen-activated protein kinases in
MSCs
We examined whether fMLF stimulates mitogen-activated
protein kinases (MAPKs) by Western blotting with anti-phos-
pho-speciﬁc antibodies to each enzyme. When MSCs were
stimulated with 1 lM fMLF for diﬀerent times, the phosphor-
ylation levels of ERK and p38 MAPK transiently increased,
showing maximal activity after 5–10 min of stimulation
(Fig. 2A). We also found that stimulation of MSCs with vari-
ous concentrations of fMLF-induced MAPK phosphoryla-pERK
A
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Fig. 2. Activation of MAPKs by fMLF in MSCs. MSCs were
stimulated with 1 lM of fMLF for various times (A). The cells were
stimulated with various concentrations of fMLF for 5 min (B). MSCs
were preincubated in the absence or presence of 100 ng/ml of PTX for
24 h. Cells were stimulated with 1 lM of fMLF for 5 min (C). Western
blot analysis was performed using anti-phospho-ERK antibody or
anti-phospho-p38 kinase antibody. The results shown are representa-
tive of at least three independent experiments (A–C).tion. FMLF-induced ERK and p38 kinase phosphorylations
in a concentration-dependent manner, showing dramatic activ-
ity at 10–1000 nM (Fig. 2B). We investigated the role of PTX-
sensitive G-protein on fMLF-induced MAPK activation.
MSCs were preincubated with 100 ng/ml of PTX prior to being
stimulated with 1 lM fMLF. Pretreatment with PTX dramat-
ically blocked ERK phosphorylation by fMLF (Fig. 2C),
showing that fMLF induces ERK activation in a PTX-sensi-
tive manner.
3.4. FMLF stimulates Akt in MSCs
Akt has been reported to play important roles in the regula-
tion of several cellular responses, such as, cell migration and
cell survival [12]. When MSCs were stimulated with 1 lM
fMLF for diﬀerent times, Akt phosphorylation was transiently
increased, showing maximal activity after 2–10 min of stimula-
tion and return to baseline 30 min after stimulation (Fig. 3A).
In addition, when MSCs were stimulated with diﬀerent con-
centrations of fMLF, Akt was activated in a concentration-
dependent manner. At 10–1000 nM fMLF caused dramatic
Akt (Fig. 3B). FMLF-induced Akt phosphorylation was found
to be almost completely inhibited by PTX (Fig. 3C), indicating
that fMLF stimulates Akt activation via a PTX-sensitive path-
way.
3.5. FMLF induces MSC chemotaxis via PTX-sensitive
G-proteins
Since FPR is a chemoattractant receptor and it is involved in
the chemotactic migration of phagocytes [4]. We investigated
the eﬀect of fMLF on MSCs chemotaxis. It was found that
fMLF induced the chemotactic migration of MSCs. Fig. 4A
shows the concentration–responsive curve of fMLF-induced
MSCs migration, and shows maximal activity at 0.1–1 lM.
When MSCs were preincubated with 100 ng/ml of PTX prior
to chemotaxis assays, the numbers of cell migrating toward
fMLF was dramatically reduced (Fig. 4A), which strongly sug-
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Fig. 4. MSC chemotaxis by fMLF and Anx-1(2–26). MSCs were preincubated in the absence or presence of 100 ng/ml of PTX for 24 h (A). Three
diﬀerently prepared MSCs were preincubated in the absence or presence of 10 lM CsH for 30 min (B). MSCs were preincubated in the absence or
presence of DMSO, LY294002 (50 lM), PD98059 (50 lM), SB203580 (20 lM), or BAPTA/AM (10 lM) for 15 min (60 min for PD98059 and
BAPTA/AM) (C). The cells (1 · 106 cells/ml in serum free aMEM) were used for chemotaxis assay in the presence of several concentrations of fMLF
(1 lM for B) for 12 h at 37C (A–C). Various concentrations of Anx-1(2–26) were used for the chemotactic migration (D). Migrated cell numbers
were determined by counting in three high power ﬁelds (400·). Data are presented as means ± S.E. of three independent experiments performed
in duplicate (A–D). * indicates results signiﬁcantly diﬀerent at the P < 0.05 probability levels as compared to the values obtained from the control
(-fMLF). # indicates results signiﬁcantly diﬀerent at the P < 0.05 probability levels as compared to the values obtained from the control (DMSO
treated).
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observed in three diﬀerently prepared MSCs (Fig. 4B). Fur-
thermore, fMLF-induced MSC chemotaxis was almost com-
pletely inhibited by CsH, indicating that fMLF induces MSC
chemotaxis via FPR (Fig. 4B). Several chemoattractants stim-
ulate phosphoinositide 3-kinase (PI3K)-mediated Akt activity,
and that the PI3K pathway is involved in the chemotactic
migration of cells [13,14]. Preincubation of cells with
LY294002 (50 lM), a well-known PI3K inhibitor, for 15 min
at 37 C prior to stimulation with fMLF was found to inhibit
cellular chemotaxis (Fig. 4C), indicating that MSC activates
the PI3K pathway and that this signaling is required for the
fMLF-induced chemotaxis of MSCs. We also examined the
roles of ERK and p38 kinase on fMLF-induced MSC chemo-
taxis. When MSCs were preincubated with PD98059 (50 lM)
or SB203580 (20 lM) prior to chemotaxis assay, fMLF-in-
duced MSC chemotaxis was found to be dramatically blocked
by PD98059, but not by SB203580 (Fig. 4C). The results indi-
cate that ERK-mediated signaling is involved in fMLF-in-
duced MSC chemotaxis. Because fMLF stimulated [Ca2+]i
increases in MSCs, we examined the role of calcium signaling
on fMLF-induced MSC chemotaxis using a calcium chelator,BAPTA/AM. At ﬁrst we observed that preincubation of MSCs
with 10 lM BAPTA/AM for 60 min prior to stimulation with
fMLF completely inhibited fMLF-induced intracellular cal-
cium increase (data not shown). As shown in Fig. 4C, BAP-
TA/AM did not aﬀect on MSC chemotaxis induced by
fMLF, indicating that calcium signaling is not required for
fMLF-induced chemotaxis.
N-terminal fragment of annexin-1, Anx-1(2–26), is an
endogenous host-derived agonist for FPR [15]. In this study
we also tested the eﬀect of annexin-1 on MSC chemotaxis.
As shown in Fig. 4D, stimulation of MSCs with several concen-
trations of Anx-1(2–26) elicited chemotactic migration of
MSCs.4. Discussion
MSC migration is crucially associated with damaged tissue
remodeling [1]. In response to tissue damage, MSCs migrate
into damaged sites along chemotactic gradient [1]. Until now
various molecules that modulate chemotactic migration of
MSCs have been reported [2,3]. FPR is also important
M.-K. Kim et al. / FEBS Letters 581 (2007) 1917–1922 1921chemoattractant receptor, and expression of FPR has been
identiﬁed mainly in phagocytic cells, including monocytes,
neutrophils, and dendritic cells [4,16]. Very recently some other
non-leukocytic cells have been demonstrated to express FPR
[5,17]. Some epithelial cells such as lung epithelial cells and
hepatocyte express FPR [18,19]. Furthermore, activation of
FPR by its selective agonist (fMLF and annexin-1) has been
shown to stimulate adhesion, motility, and chemotactic migra-
tion of these epithelial cells [18,19]. However, the role of FPR
agonists in MSC chemotaxis has not been studied. In the pres-
ent study, we found that MSCs express functional FPR and its
speciﬁc agonists (fMLF and Anx-1(2–26)) stimulate the che-
motactic migration of the cells. This ﬁnding suggests that
FPR has a potential role in tissue remodeling, wound healing,
and various functional aspects related to MSC migration.
Previously annexin-1, a family of phospholipid-binding pro-
teins, has been reported to be found in many tissues such as
lung, bone marrow, and intestine [20]. Annexin-1 is also
known as a 2–4% of the total cytosolic protein in neutrophils
[21]. Annexin-1 has been reported to regulate several cellular
responses [22,23]. Annexin-1 is involved in membrane traﬃck-
ing and epithelial cell migration and invasion [17]. In Fig. 4D,
we demonstrated that Anx-1(2–26), an endogenous FPR
agonist, induced chemotactic migration of MSCs. Since in
this study we demonstrated that Anx-1(2–26) induced chemo-
tactic migration of MSCs, we suggest a new aspect of annexin-
1 as a regulator of MSC migration which is need for tissue
repairing.
In our study we also investigated the eﬀect of PTX, which
speciﬁcally blocks the coupling of G-protein-coupled receptors
to Gi, on fMLF-induced signaling. When MSCs were treated
with 100 ng/ml of PTX for 24 h prior to fMLF stimulation,
fMLF-induced intracellular calcium elevation, ERK phos-
phorylation, and Akt phosphorylation were almost completely
inhibited (Figs. 1D, 2C and 3C). Furthermore, fMLF-induced
chemotactic migration was also completely inhibited by PTX
treatment, as shown in Fig. 4A. These results were correlated
with previous reports that demonstrate fMLF utilizes PTX-
sensitive G-protein-coupled receptor, FPR [4]. We also found
that fMLF-induced MSC chemotaxis via PI3K, and ERK
pathways (Fig. 4C). However, phospholipase C-mediated cal-
cium signaling pathway and p38 kinase pathway were not
found to be involved in fMLF-induced chemotaxis (Fig. 4C).
In view of the fact that calcium signaling and p38 kinase reg-
ulate several kinds of cellular physiologies and that fMLF
stimulates phospholipase C-mediated intracellular calcium in-
crease and p38 kinase, it would be interesting to know the
other functional roles of fMLF in MSCs related to calcium sig-
naling or p38 kinase-dependent processes.
In conclusion, the present study shows that MSCs express
FPR and two of FPR agonists (fMLF and Anx-1(2–26)) in-
duce chemotactic migration of MSCs. Since this study de-
scribes the functional expression of FPR and role of its
agonists in MSC chemotaxis, further studies on the pathologic
and physiologic roles of FPR and its speciﬁc agonists are re-
quired.
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